Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real World Study of Lecanemab Treatment in Participants with Early Onset Familial Alzheimer's Disease

NCT06883019 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06883019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06883019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real World Study of Lecanemab Treatment in Participants with Early Onset Familial Alzheimer's Disease
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 13, 2025
Completion date
August 31, 2027
Enrollment
114 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease